NO20022739D0 - Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelser - Google Patents

Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelser

Info

Publication number
NO20022739D0
NO20022739D0 NO20022739A NO20022739A NO20022739D0 NO 20022739 D0 NO20022739 D0 NO 20022739D0 NO 20022739 A NO20022739 A NO 20022739A NO 20022739 A NO20022739 A NO 20022739A NO 20022739 D0 NO20022739 D0 NO 20022739D0
Authority
NO
Norway
Prior art keywords
prevention
treatment
dioxino
neuroleptics
benzylamino
Prior art date
Application number
NO20022739A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022739L (no
Inventor
Karen Lovell Marquis
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20022739D0 publication Critical patent/NO20022739D0/no
Publication of NO20022739L publication Critical patent/NO20022739L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20022739A 1999-12-10 2002-06-07 Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser NO20022739L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10
PCT/US2000/033060 WO2001041750A2 (en) 1999-12-10 2000-12-07 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (2)

Publication Number Publication Date
NO20022739D0 true NO20022739D0 (no) 2002-06-07
NO20022739L NO20022739L (no) 2002-06-07

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022739A NO20022739L (no) 1999-12-10 2002-06-07 Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser

Country Status (20)

Country Link
EP (1) EP1235570A2 (zh)
JP (1) JP5557409B2 (zh)
KR (1) KR100772854B1 (zh)
CN (1) CN1230164C (zh)
AR (1) AR026756A1 (zh)
AU (1) AU784211B2 (zh)
BR (1) BR0016168A (zh)
CA (1) CA2396351C (zh)
CZ (1) CZ20021880A3 (zh)
EA (1) EA005002B1 (zh)
HK (1) HK1045942A1 (zh)
HU (1) HUP0203309A3 (zh)
IL (2) IL149669A0 (zh)
MX (1) MXPA02005649A (zh)
NO (1) NO20022739L (zh)
NZ (1) NZ519381A (zh)
PL (1) PL355292A1 (zh)
TW (1) TWI222864B (zh)
WO (1) WO2001041750A2 (zh)
ZA (1) ZA200205484B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200400218A (es) 2003-10-29 2005-06-06 Formulaciones de liberacion sostenida.
BRPI0608353A2 (pt) 2005-02-17 2009-12-01 Wyeth Corp derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfundidos
RU2481123C2 (ru) * 2008-02-13 2013-05-10 Таргасепт, Инк. Комбинация агонистов альфа 7 никотиновых рецепторов и антипсихотических средств

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (ja) * 1995-03-16 1999-12-06 大塚製薬 株式会社 カルボスチリル誘導体の製造方法
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
TWI222864B (en) 2004-11-01
MXPA02005649A (es) 2004-09-10
WO2001041750A3 (en) 2002-02-14
IL149669A (en) 2006-06-11
HUP0203309A2 (hu) 2003-01-28
PL355292A1 (en) 2004-04-05
AU1949001A (en) 2001-06-18
WO2001041750A2 (en) 2001-06-14
EA005002B1 (ru) 2004-10-28
EP1235570A2 (en) 2002-09-04
CZ20021880A3 (cs) 2002-08-14
HUP0203309A3 (en) 2004-12-28
KR100772854B1 (ko) 2007-11-02
NO20022739L (no) 2002-06-07
ZA200205484B (en) 2003-12-31
JP5557409B2 (ja) 2014-07-23
NZ519381A (en) 2004-04-30
AU784211B2 (en) 2006-02-23
CA2396351C (en) 2009-11-10
HK1045942A1 (zh) 2002-12-20
CN1409633A (zh) 2003-04-09
IL149669A0 (en) 2002-11-10
CA2396351A1 (en) 2001-06-14
BR0016168A (pt) 2002-08-20
AR026756A1 (es) 2003-02-26
KR20030016207A (ko) 2003-02-26
CN1230164C (zh) 2005-12-07
JP2003516350A (ja) 2003-05-13
EA200200656A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
TWI265808B (en) Valdecoxib compositions
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
EP1259240B8 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
NO306779B1 (no) Naftalamider, anvendelse derav og farmasöytisk preparat
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
ES2173887T3 (es) Nuevos usos farmaceuticos de las enzimas de krill.
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
SE9802208D0 (sv) Novel compounds
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
RS11104A (en) Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
SE0001916D0 (sv) Novel formulation
TR200200278T2 (tr) Kalsilitik bileşimler
NO20022739D0 (no) Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelser
MX9805065A (es) Nuevos derivados bi-aromaticos del dibenzofurano y su utilizacion en medicina humana o veterinaria asi como en cosmetica.
JO2199B1 (en) Replaced pyrrols
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
TR199901385T2 (xx) Piperidin t�revleri.
WO2003080568A3 (en) Probucol derivatives
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application